Evidence map›Paper›PMID 25897619›Full record

ArticleBiochemistry2015

Tuning the production of variable length, fluorescent polyisoprenoids using surfactant-controlled enzymatic synthesis.

Jerry M Troutman, Katelyn M Erickson, Phillip M Scott, Joseph M Hazel, Christina D Martinez, Samantha Dodbele

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jerry M Troutman†Department of Chemistry, ‡Nanoscale Science Program, and §The Center for Biomedical Engineering and Science, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, North Carolina 28223, United States.
Katelyn M Erickson†Department of Chemistry, ‡Nanoscale Science Program, and §The Center for Biomedical Engineering and Science, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, North Carolina 28223, United States.
Phillip M Scott†Department of Chemistry, ‡Nanoscale Science Program, and §The Center for Biomedical Engineering and Science, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, North Carolina 28223, United States.
Joseph M Hazel†Department of Chemistry, ‡Nanoscale Science Program, and §The Center for Biomedical Engineering and Science, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, North Carolina 28223, United States.
Christina D Martinez†Department of Chemistry, ‡Nanoscale Science Program, and §The Center for Biomedical Engineering and Science, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, North Carolina 28223, United States.
Samantha Dodbele†Department of Chemistry, ‡Nanoscale Science Program, and §The Center for Biomedical Engineering and Science, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, North Carolina 28223, United States.
University of North Carolina at Charlotte · US

Funding

Toolkit development for bacterial isoprenoid utilizing enzymesR15GM114773 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI TROUTMAN, JERRY M · 2015 to 2015
$350k
Biosynthesis of the Immunomodulatory Molecule Capsular Polysaccharide AR15GM100402 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI TROUTMAN, JERRY M · 2012 to 2012
$321k
NIGMS NIH HHS R15 GM100402NIGMS NIH HHS R15GM100402NIGMS NIH HHS R15 GM114773NIGMS NIH HHS R15GM114773
6 · The paper itself

Abstract

Bactoprenyl diphosphate (BPP), a two-E eight-Z configuration C55 isoprenoid, serves as a critical anchor for the biosynthesis of complex glycans central to bacterial survival and pathogenesis. BPP is formed by the polymerase undecaprenyl pyrophosphate synthase (UppS), which catalyzes the elongation of a single farnesyl diphosphate (FPP) with eight Z-configuration isoprene units from eight isopentenyl diphosphates. In vitro analysis of UppS and other polyprenyl diphosphate synthases requires the addition of a surfactant such as Triton X-100 to stimulate the release of the hydrophobic product from the enzyme for effective and efficient turnover. Here using a fluorescent 2-nitrileanilinogeranyl diphosphate analogue of FPP, we have found that a wide range of surfactants can stimulate release of product from UppS and that the structure of the surfactant has a major impact on the lengths of products produced by the protein. Of particular importance, shorter chain surfactants promote the release of isoprenoids with four to six Z-configuration isoprene additions, while larger chain surfactants promote the formation of natural isoprenoid lengths (8Z) and larger. We have found that the product chain lengths can be readily controlled and coarsely tuned by adjusting surfactant identity, concentration, and reaction time. We have also found that binary mixtures of just two surfactants can be used to fine-tune isoprenoid lengths. The surfactant effects discovered do not appear to be significantly altered with an alternative isoprenoid substrate. However, the surfactant effects do appear to be dependent on differences in UppS between bacterial species. This work provides new insights into surfactant effects in enzymology and highlights how these effects can be leveraged for the chemoenzymatic synthesis of otherwise difficult to obtain glycan biosynthesis probes. This work also provides key reagents for the systematic analysis of structure-activity relationships between glycan biosynthesis enzymes and isoprenoid structure.

Indexed as

Alkyl and Aryl TransferasesBacterial ProteinsBacteroides fragilisFluorescent DyesStereoisomerismSurface-Active AgentsTerpenesTime FactorsAlkyl and Aryl TransferasesBacterial ProteinsFluorescent DyesSurface-Active AgentsTerpenesundecaprenyl pyrophosphate synthetase

Identifiers

PMID25897619
PMCPMC4455894
OpenAlexW2328229819

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.